TOP - Daily

More than one-third of US physicians often or sometimes prescribe brand-name drugs when appropriate generic substitutes are available. Read More ›

Researchers recently assessed the widespread implementation of CT scanning for the early detection of lung cancer in a public health setting. Read More ›

Over the last 10 years, the use of preventive cancer screenings has fallen in the United States. Read More ›

According to recent research figures, a man’s lifetime risk of developing cancer will be 1 in 2 by 2027. Read More ›

When determining how well tamoxifen works, new study results provide evidence that genetic differences in the enzyme CYP2D6 play a key role. Read More ›

A national drug shortage of mechlorethamine has been linked to a higher rate of relapse among children, teenagers, and young adults with Hodgkin lymphoma enrolled in a national clinical trial. Read More ›

For those who have been affected by cancer, the holidays can be stressful and anxiety-ridden. Read More ›

A recent study has determined that chronic obstructive pulmonary disease (COPD) is not an independent risk factor for lung cancer. Read More ›

Results from a retrospective analysis of more than 36,000 individuals with colon cancer indicated that patients with early-stage disease plus diabetes or high blood pressure have an increased risk of death or cancer recurrence compared with those colon cancer patients without either condition. Read More ›

A variety of therapies exist for the severe, debilitating fatigue that often follows cancer treatments. Read More ›